Analyze Diet
Animals : an open access journal from MDPI2025; 15(19); 2905; doi: 10.3390/ani15192905

Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction.

Abstract: Fifty-two horses aged >15 years, diagnosed with pituitary pars intermedia dysfunction (PPID), and displaying hypertrichosis were recruited via an online survey of PPID horse owners. From mid-December, group T ( = 29) wore Equilume light masks extending photoperiod to 15 h daily, while group C1 ( = 23) remained under natural photoperiod. As 85% (44/52) of recruited study horses received pergolide medication, a second unmedicated PPID research herd (C2; = 17) was recruited and remained under natural photoperiod. Hair coat samples, shedding and body condition scores were collected monthly by owners for 13 months and analysed by the research team. Data related to management, coat condition and PPID clinical signs were collected using bimonthly questionnaires (BMQ). Time ( < 0.001), group ( = 0.025) and time-by-group interaction ( = 0.005) affected hair length. Group differences were attributable to shorter hair lengths in C2, and no differences in hair length occurred between T and C1 ( > 0.05). Time affected shedding scores ( < 0.001) which was advanced by one month in T ( < 0.05). In group T, BMQ responses showed improved coat condition in April ( = 0.035), decreased fat coverage in April and June ( < 0.05), and increased energy/alertness in February ( = 0.022). Improvements in coat condition ( = 0.043), clinical signs of PPID ( = 0.018), and general quality of life ( = 0.035) were reported in T only in a final study questionnaire. Blue light treatment merits further investigation as a complementary treatment for PPID.
Publication Date: 2025-10-05 PubMed ID: 41096500PubMed Central: PMC12523991DOI: 10.3390/ani15192905Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

Overview

  • This study investigated the effects of extending daily light exposure using blue light masks on horses with pituitary pars intermedia dysfunction (PPID), focusing on hair growth, coat condition, and overall health.
  • Researchers compared horses receiving blue light therapy to those under natural light conditions, examining hair length, shedding, body condition, and clinical symptoms over 13 months.

Background

  • PPID, also known as equine Cushing’s disease, is a common hormonal disorder in older horses, typically those older than 15 years.
  • The condition often leads to hypertrichosis, which is excessive hair growth, poor coat condition, and other general health issues.
  • Management of PPID usually involves medication such as pergolide, but complementary treatments that might improve symptoms are of interest.
  • Photoperiod, or the length of daily light exposure, has been shown to influence hair growth and shedding cycles in horses.
  • Blue light masks are a novel approach to artificially extend the photoperiod, potentially improving endocrine-related symptoms.

Study Design

  • Participants: 52 horses diagnosed with PPID, exhibiting hypertrichosis, mostly aged over 15 years.
  • Grouping:
    • Group T (n=29): Wore Equilume blue light masks to extend photoperiod to 15 hours daily from mid-December.
    • Group C1 (n=23): Control group under natural photoperiod, most receiving standard pergolide medication.
    • Group C2 (n=17): Unmedicated PPID horses, serving as a second control group under natural photoperiod to account for medication effects.
  • Data Collection:
    • Monthly hair coat samples, shedding assessments, and body condition scoring conducted by horse owners for 13 months.
    • Bimonthly questionnaires to collect data on management, coat condition, and PPID clinical signs.

Key Findings

  • Hair Length:
    • Time (seasonal changes), group membership, and their interaction influenced hair length significantly.
    • Group C2 (unmedicated controls) had shorter hair compared to other groups, indicating natural shedding or better condition without medication.
    • No significant difference in hair length between the blue light treatment group (T) and medicated control group (C1) was found.
  • Shedding Scores:
    • Shedding progressed over time for all groups, but in the blue light group (T), shedding occurred one month earlier, suggesting that extended light exposure may accelerate the shedding cycle.
  • Body Condition and Energy:
    • Owners reported improved coat condition in the blue light group (T) in April.
    • Decreased fat coverage scores, possibly indicating healthier body condition, were noted in April and June in group T.
    • Increased energy and alertness were also reported for the blue light group in February.
  • Overall Health and Clinical Signs:
    • Only horses in the blue light treatment group reported improvements in coat condition, clinical signs of PPID, and general quality of life by study end.
    • These improvements suggest potential therapeutic benefits from extending photoperiod using blue light masks beyond medication alone.

Conclusions and Implications

  • Blue light masks that extend daily light exposure show promise as a complementary treatment for horses with PPID.
  • The intervention may help advance natural hair shedding cycles and improve coat quality and general health status.
  • While blue light treatment did not reduce hair length compared to medicated controls, it positively impacted other clinical signs and subjective health parameters.
  • Further research is recommended to confirm these findings, optimize treatment protocols, and understand mechanisms.
  • This approach could represent a non-pharmacological adjunct therapy, potentially improving quality of life in affected horses.

Cite This Article

APA
Parmantier S, Kyriazopoulou P, McClendon M, Adams A, Murphy BA. (2025). Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction. Animals (Basel), 15(19), 2905. https://doi.org/10.3390/ani15192905

Publication

ISSN: 2076-2615
NlmUniqueID: 101635614
Country: Switzerland
Language: English
Volume: 15
Issue: 19
PII: 2905

Researcher Affiliations

Parmantier, Sinead
  • School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.
Kyriazopoulou, Panoraia
  • Equilume Ltd., Ladytown Business Park, Naas, W91 TP22 Co. Kildare, Ireland.
McClendon, Margaret
  • M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Adams, Amanda
  • M.H. Gluck Equine Research Center, Department of Veterinary Science, University of Kentucky, Lexington, KY 40546, USA.
Murphy, Barbara A
  • School of Agriculture and Food Science, University College Dublin, Belfield, Dublin 4, Ireland.

Grant Funding

  • n/a / Equilume (Ireland)
  • n/a / University College Dublin
  • n/a / University of Kentucky

Conflict of Interest Statement

B.A.M is a cofounder of Equilume Ltd., a spin-out company deriving from her research as associate professor at University College Dublin and is a member of the company’s board of directors. P.K. was an employee of Equilume Ltd. in the role of research manager at the time of the study.

References

This article includes 78 references
  1. Ireland JL, McGowan CM. Epidemiology of Pituitary Pars Intermedia Dysfunction: A Systematic Literature Review of Clinical Presentation, Disease Prevalence and Risk Factors.. Vet. J. 2018;235:22–33.
    doi: 10.1016/j.tvjl.2018.03.002pubmed: 29704935google scholar: lookup
  2. Mcgowan TW, Pinchbeck GP, Mcgowan CM. Prevalence, Risk Factors and Clinical Signs Predictive for Equine Pituitary Pars Intermedia Dysfunction in Aged Horses.. Equine Vet. J. 2013;45:74–79.
  3. Kirkwood NC, Hughes KJ, Stewart AJ. Pituitary Pars Intermedia Dysfunction (PPID) in Horses.. Vet. Sci. 2022;9:556.
    doi: 10.3390/vetsci9100556pmc: PMC9611634pubmed: 36288169google scholar: lookup
  4. Durham AE, Clarke BR, Potier JFN, Hammarstrand R, Malone GL. Clinically and Temporally Specific Diagnostic Thresholds for Plasma ACTH in the Horse.. Equine Vet. J. 2021;53:250–260.
    doi: 10.1111/evj.13292pubmed: 32470177google scholar: lookup
  5. Durham AE, Potier JF, Huber L. The Effect of Month and Breed on Plasma Adrenocorticotropic Hormone Concentrations in Equids.. Vet. J. 2022;286:105857.
    doi: 10.1016/j.tvjl.2022.105857pubmed: 35798232google scholar: lookup
  6. Horn R, Stewart AJ, Jackson KV, Dryburgh EL, Medina-Torres CE, Bertin F. Clinical Implications of Using Adrenocorticotropic Hormone Diagnostic Cutoffs or Reference Intervals to Diagnose Pituitary Pars Intermedia Dysfunction in Mature Horses.. Vet. Intern. Med. 2021;35:560–570.
    doi: 10.1111/jvim.16017pmc: PMC7848300pubmed: 33368633google scholar: lookup
  7. McFarlane D. Equine Pituitary Pars Intermedia Dysfunction.. Vet. Clin. N. Am. Equine Pract. 2011;27:93–113.
    doi: 10.1016/j.cveq.2010.12.007pubmed: 21392656google scholar: lookup
  8. . Recommendations for the Diagnosis and Management of Pituitary Pars Intermedia Dysfunction (PPID) 2023.. .
  9. Innerå M, Petersen AD, Desjardins DR, Steficek BA, Rosser EJ, Schott HC. Comparison of Hair Follicle Histology between Horses with Pituitary Pars Intermedia Dysfunction and Excessive Hair Growth and Normal Aged Horses.. Vet. Dermatol. 2013;24:212.
  10. Scott DW, Miller WH. Equine Dermatology.. Elsevier; Amsterdam, The Netherlands: 2003. Endocrine, Nutritional, and Miscellaneous Haircoat Disorders; pp. 548–570.
  11. Aleman M, Watson JL, Williams DC, LeCouteur RA, Nieto JE, Shelton GD. Myopathy in Horses with Pituitary Pars Intermedia Dysfunction (Cushing’s Disease). Neuromuscul. Disord. 2006;16:737–744.
    doi: 10.1016/j.nmd.2006.07.019pubmed: 17005399google scholar: lookup
  12. Glover CM, Miller LM, Dybdal NO, Lopez A, Duckett WM, McFarlane D. Extrapituitary and Pituitary Pathological Findings in Horses with Pituitary Pars Intermedia Dysfunction: A Retrospective Study.. J. Equine Vet. Sci. 2009;29:146–153.
  13. Horn R, Bamford NJ, Afonso T, Sutherland M, Buckerfield J, Tan RHH, Secombe CJ, Stewart AJ, Bertin FR. Factors Associated with Survival, Laminitis and Insulin Dysregulation in Horses Diagnosed with Equine Pituitary Pars Intermedia Dysfunction.. Equine Vet. J. 2019;51:440–445.
    doi: 10.1111/evj.13041pubmed: 30417404google scholar: lookup
  14. Menzies-Gow NJ, Banse HE, Duff A, Hart N, Ireland JL, Knowles EJ, McFarlane D, Rendle D. BEVA Primary Care Clinical Guidelines: Diagnosis and Management of Equine Pituitary Pars Intermedia Dysfunction.. Equine Vet. J. 2024;56:220–242.
    doi: 10.1111/evj.14009pubmed: 37795557google scholar: lookup
  15. Gebbie FE, Forsyth IA, Arendt J. Effects of Maintaining Solstice Light and Temperature on Reproductive Activity, Coat Growth, Plasma Prolactin and Melatonin in Goats.. Reproduction. 1999;116:25–33.
    doi: 10.1530/jrf.0.1160025pubmed: 10505053google scholar: lookup
  16. Guerin MV, Wang XJ. Environmental Temperature Has an Influence on Timing of the First Ovulation of Seasonal Estrus in the Mare. Theriogenology 1994;42:1053–1060.
    doi: 10.1016/0093-691X(94)90127-5pubmed: 16727609google scholar: lookup
  17. Schmidt K, Deichsel K, De Oliveira RA, Aurich J, Ille N, Aurich C. Effects of Environmental Temperature and Season on Hair Coat Characteristics, Physiologic and Reproductive Parameters in Shetland Pony Stallions. Theriogenology 2017;97:170–178.
  18. Geyfman M, Plikus MV, Treffeisen E, Andersen B, Paus R. Resting No More: Re-defining Telogen, the Maintenance Stage of the Hair Growth Cycle. Biol. Rev. 2015;90:1179–1196.
    doi: 10.1111/brv.12151pmc: PMC4437968pubmed: 25410793google scholar: lookup
  19. Martinet L, Allain D, Weiner C. Role of Prolactin in the Photoperiodic Control of Moulting in the Mink (Mustela Vison). J. Endocrinol. 1984;103:9–15.
    doi: 10.1677/joe.0.1030009pubmed: 6481296google scholar: lookup
  20. O’Brien C, Darcy-Dunne MR, Murphy BA. The Effects of Extended Photoperiod and Warmth on Hair Growth in Ponies and Horses at Different Times of Year. PLoS ONE 2020;15:e0227115.
  21. Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, Jasser S, Gerner E, Rollag MD. Sensitivity of the Human Circadian System to Short-Wavelength (420-Nm) Light. J. Biol. Rhythm. 2008;23:379–386.
    doi: 10.1177/0748730408323089pubmed: 18838601google scholar: lookup
  22. Wahl S, Engelhardt M, Schaupp P, Lappe C, Ivanov IV. The Inner Clock—Blue Light Sets the Human Rhythm. J. Biophotonics 2019;12:e201900102.
    doi: 10.1002/jbio.201900102pmc: PMC7065627pubmed: 31433569google scholar: lookup
  23. Murphy BA. Circadian and Circannual Regulation in the Horse: Internal Timing in an Elite Athlete. J. Equine Vet. Sci. 2019;76:14–24.
    doi: 10.1016/j.jevs.2019.02.026pubmed: 31084748google scholar: lookup
  24. Fitzgerald BP, McManus CJ. Photoperiodic Versus Metabolic Signals as Determinants of Seasonal Anestrus in the Mare1. Biol. Reprod. 2000;63:335–340.
    doi: 10.1095/biolreprod63.1.335pubmed: 10859276google scholar: lookup
  25. Chu Y, Shieh K, Yuan ZF, Pan J. Stimulatory and Entraining Effect of Melatonin on Tuberoinfundibular Dopaminergic Neuron Activity and Inhibition on Prolactin Secretion. J. Pineal Res. 2000;28:219–226.
  26. Li H, Wei J, Ma F, Shan Q, Gao D, Jin Y, Sun P. Melatonin Modulates Lactation by Regulating Prolactin Secretion Via Tuberoinfundibular Dopaminergic Neurons in the Hypothalamus- Pituitary System. Chronic Pelvic Pain Syndr. 2020;21:744–750.
  27. Craven AJ, Ormandy CJ, Robertson FG, Wilkins RJ, Kelly PA, Nixon AJ, Pearson AJ. Prolactin Signaling Influences the Timing Mechanism of the Hair Follicle: Analysis of Hair Growth Cycles in Prolactin Receptor Knockout Mice. Endocrinology 2001;142:2533–2539.
    doi: 10.1210/endo.142.6.8179pubmed: 11356702google scholar: lookup
  28. Grymowicz M, Rudnicka E, Podfigurna A, Napierala P, Smolarczyk R, Smolarczyk K, Meczekalski B. Hormonal Effects on Hair Follicles. Int. J. Mol. Sci. 2020;21:5342.
    doi: 10.3390/ijms21155342pmc: PMC7432488pubmed: 32731328google scholar: lookup
  29. Tatum RC, McGowan CM, Ireland JL. Efficacy of Pergolide for the Management of Equine Pituitary Pars Intermedia Dysfunction: A Systematic Review. Vet. J. 2020;266:105562.
    doi: 10.1016/j.tvjl.2020.105562pubmed: 33323174google scholar: lookup
  30. Dunkel B, Wilford SA, Parkinson NJ, Ward C, Smith P, Grahame L, Brazil T, Schott HC. Severe Hypertriglyceridaemia in Horses and Ponies with Endocrine Disorders. Equine Vet. J. 2014;46:118–122.
    doi: 10.1111/evj.12089pubmed: 23663085google scholar: lookup
  31. Perkins GA, Lamb S, Erb HN, Schanbacher B, Nydam DV, Divers TJ. Plasma Adrenocorticotropin (ACTH) Concentrations and Clinical Response in Horses Treated for Equine Cushing’s Disease with Cyproheptadine or Pergolide. Equine Vet. J. 2002;34:679–685.
    doi: 10.2746/042516402776250333pubmed: 12455838google scholar: lookup
  32. Pongratz MC, Graubner C, Wehrli Eser M. Equine Cushing’s Syndrome: Long-term effect of Pergolide therapy. Pferdeheilkunde 2010;26:598–603.
    doi: 10.21836/PEM20100416google scholar: lookup
  33. Love S. Equine Cushing’s Disease. Br. Vet. J. 1993;149:139–153.
    doi: 10.1016/s0007-1935(05)80084-3pubmed: 8485640google scholar: lookup
  34. Rendle DI, Taylor E, Duz M, Parkin TD, Copas VEN, Durham AE. Effects of Pergolide Mesylate on Plasma Adrenocorticotropic Hormone Concentration in Horses with Pituitary Pars Intermedia Dysfunction. Equine Vet. J. 2013;45:19.
    doi: 10.1111/evj.12145_48google scholar: lookup
  35. Schott HC, Strachota JR, Marteniuk JV, Refsal KR. Long-Term Response of Equids with Pituitary Pars Intermedia Dysfunction to Treatment with Pergolide. Vet. Intern. Med. 2025;39.
    doi: 10.1111/jvim.70109pmc: PMC12046498pubmed: 40317948google scholar: lookup
  36. Muñoz MC, Doreste F, Ferrer O, González J, Montoya JA. Pergolide Treatment for Cushing’s Syndrome in a Horse. Vet. Rec. 1996;139:41–43.
    doi: 10.1136/vr.139.2.41pubmed: 8839490google scholar: lookup
  37. Gehlen H, May A, Bradaric Z. Comparison of Insulin and Glucose Metabolism in Horses with Pituitary Pars Intermedia Dysfunction Treated Versus Not Treated with Pergolide. J. Equine Vet. Sci. 2014;34:508–513.
  38. Schwarz B, Ihry P. Accidental Overdose of Pergolide (Prascend) Followed by Loss of Appetite, Tachycardia, and Behavioral Abnormalities in a Pony Mare. J. Equine Vet. Sci. 2020;92:103181.
    doi: 10.1016/j.jevs.2020.103181pubmed: 32797773google scholar: lookup
  39. Hague N, Durham AE, Menzies-Gow NJ. Pergolide Dosing Compliance and Factors Affecting the Laboratory Control of Equine Pituitary Pars Intermedia Dysfunction. Vet. Rec. 2021;189:e142.
    doi: 10.1002/vetr.142pubmed: 33759215google scholar: lookup
  40. Lutzer A, Nagel C, Murphy BA, Aurich J, Wulf M, Gautier C, Aurich C. Effects of Blue Monochromatic Light Directed at One Eye of Pregnant Horse Mares on Gestation, Parturition and Foal Maturity. Domest. Anim. Endocrinol. 2022;78:106675.
  41. Murphy BA, Walsh CM, Woodward EM, Prendergast RL, Ryle JP, Fallon LH, Troedsson MHT. Blue Light from Individual Light Masks Directed at a Single Eye Advances the Breeding Season in Mares. Equine Vet. J. 2014;46:601–605.
    doi: 10.1111/evj.12153pubmed: 23909505google scholar: lookup
  42. Nolan MB, Walsh CM, Duff N, McCrarren C, Prendergast RL, Murphy BA. Artificially Extended Photoperiod Administered to Pre-Partum Mares via Blue Light to a Single Eye: Observations on Gestation Length, Foal Birth Weight and Foal Hair Coat at Birth. Theriogenology 2017;100:126–133.
  43. Walsh CM, Prendergast RL, Sheridan JT, Murphy BA. Blue Light from Light-Emitting Diodes Directed at a Single Eye Elicits a Dose-Dependent Suppression of Melatonin in Horses. Vet. J. 2013;196:231–235.
    doi: 10.1016/j.tvjl.2012.09.003pubmed: 23079244google scholar: lookup
  44. Miller AB, Murphy BA, Adams AA. Impact of Blue Light Therapy on Plasma Adrenocorticotropic Hormone (ACTH) and Hypertrichosis in Horses with Pituitary Pars Intermedia Dysfunction. Domest. Anim. Endocrinol. 2022;78:106651.
  45. Ishimaru M, Okano A, Matsui A, Murase H, Korosue K, Akiyama K, Taya K. Effects of an Extended Photoperiod on Body Composition of Young Thoroughbreds in Training. J. Vet. Med. Sci. 2024;86:58–65.
    doi: 10.1292/jvms.23-0349pmc: PMC10849847pubmed: 37967974google scholar: lookup
  46. Farhud D, Aryan Z. Circadian Rhythm, Lifestyle and Health: A Narrative Review. Iran J. Public Health 2018;47:1068–1076.
    pmc: PMC6123576pubmed: 30186777
  47. Killgore WDS, Dailey NS, Raikes AC, Vanuk JR, Taylor E, Alkozei A. Blue Light Exposure Enhances Neural Efficiency of the Task Positive Network during a Cognitive Interference Task. Neurosci. Lett. 2020;735:135242.
    doi: 10.1016/j.neulet.2020.135242pubmed: 32652208google scholar: lookup
  48. Li H, Li K, Zhang K, Li Y, Gu H, Liu H, Yang Z, Cai D. The Circadian Physiology: Implications in Livestock Health. Int. J. Mol. Sci. 2021;22:2111.
    doi: 10.3390/ijms22042111pmc: PMC7924354pubmed: 33672703google scholar: lookup
  49. Milosavljevic N. How Does Light Regulate Mood and Behavioral State?. Clocks Sleep 2019;1:319–331.
    doi: 10.3390/clockssleep1030027pmc: PMC7445808pubmed: 33089172google scholar: lookup
  50. Poole J, Kitchen GB. Circadian Regulation of Innate Immunity in Animals and Humans and Implications for Human Disease. Semin. Immunopathol. 2022;44:183–192.
    doi: 10.1007/s00281-022-00921-zpmc: PMC8853148pubmed: 35169890google scholar: lookup
  51. Parmantier S, Kyriazopoulou P, McClendon M, Adams A, Murphy BA. Influence of Extended Photoperiod Using Blue Light Masks on Hypertrichosis, Coat Condition, and General Health Parameters in Horses with Pituitary Pars Intermedia Dysfunction. J. Equine Vet. Sci. 2025;148:105534.
  52. Henneke DR, Potter GD, Kreider JL, Yeates BF. Relationship between Condition Score, Physical Measurements and Body Fat Percentage in Mares. Equine Vet. J. 1983;15:371–372.
  53. Kemp W, Bashir A, Dababneh H, Cohen-Gadol A. Cushing’s Ulcer: Further Reflections. Asian J. Neurosurg. 2015;10:87–94.
    doi: 10.4103/1793-5482.154976pmc: PMC4421974pubmed: 25972936google scholar: lookup
  54. Kuan EC, Peng KA, Suh JD, Bergsneider M, Wang MB. Otolaryngic Manifestations of Cushing Disease. Ear Nose Throat J. 2017;96:E28–E30.
    doi: 10.1177/014556131709600808pubmed: 28846797google scholar: lookup
  55. Osthaus B, Proops L, Long S, Bell N, Hayday K, Burden F. Hair Coat Properties of Donkeys, Mules and Horses in a Temperate Climate. Equine Vet. J. 2018;50:339–342.
    doi: 10.1111/evj.12775pmc: PMC5900864pubmed: 29053900google scholar: lookup
  56. . Circadian Physiology. Neuroscience in the 21st Century Springer; New York, NY, USA: 2013; pp. 1813–1845.
  57. Kooistra LH, Ginther OJ. Effect of Photoperiod on Reproductive Activity and Hair in Mares. Am. J. Vet. Res. 1975;36:1413–1419.
    doi: 10.2460/ajvr.1975.36.10.1413pubmed: 1238038google scholar: lookup
  58. Palmer E, Driancourt MA, Ortavant R. Photoperiodic Stimulation of the Mare during Winter Anoestrus. J. Reprod. Fertil. Suppl. 1982;32:275–282.
    pubmed: 6820061
  59. Meisfjord Jørgensen GH, Mejdell CM, Bøe KE. Effects of Hair Coat Characteristics on Radiant Surface Temperature in Horses. J. Therm. Biol. 2020;87:102474.
  60. DeBoer M, Konop A, Fisher B. Changes in Hair Coat Length and Diameter in Blanketed and Nonblanketed Adult Horses in the Winter. J. Equine Vet. Sci. 2023;120:104191.
    doi: 10.1016/j.jevs.2022.104191pubmed: 36509241google scholar: lookup
  61. Paus R, Cotsarelis G. The Biology of Hair Follicles. N. Engl. J. Med. 1999;341:491–497.
    doi: 10.1056/NEJM199908123410706pubmed: 10441606google scholar: lookup
  62. Nixon AJ, Ashby MG, Saywell DP, Pearson AJ. Seasonal Fiber Growth Cycles of Ferrets (Mustela Putorius Furo) and Long-term Effects of Melatonin Treatment. J. Exp. Zool. 1995;272:435–445.
    doi: 10.1002/jez.1402720605pubmed: 7673877google scholar: lookup
  63. Tadros EM, Frank N. Endocrine Disorders and Laminitis. Equine Vet. Educ. 2013;25:152–162.
  64. Greening L, Harkin E, Kyriazopoulou P, Heppelthwaite Z, Aragona F, Browne JA, Hemmings A, Williams JM, Murphy BA. Influence of Lighting on Sleep Behaviour, Circadian Rhythm and Spontaneous Blink Rate in Stabled Riding School Horses (Equus Caballus). PLoS ONE 2025;20:e0326567.
  65. Cajochen C, Münch M, Kobialka S, Kräuchi K, Steiner R, Oelhafen P, Orgül S, Wirz-Justice A. High Sensitivity of Human Melatonin, Alertness, Thermoregulation, and Heart Rate to Short Wavelength Light. J. Clin. Endocrinol. Metab. 2005;90:1311–1316.
    doi: 10.1210/jc.2004-0957pubmed: 15585546google scholar: lookup
  66. Videnovic A, Klerman EB, Wang W, Marconi A, Kuhta T, Zee PC. Timed Light Therapy for Sleep and Daytime Sleepiness Associated with Parkinson Disease: A Randomized Clinical Trial. JAMA Neurol. 2017;74:411.
  67. Charkhabi SA, Sharifi Z, Janizadeh R, Rahdar M, Kazemi R. The Effect of Blue Light on Cognitive Function at Workplaces: A Systematic Review. Physiol. Behav. 2025;289:114758.
    doi: 10.1016/j.physbeh.2024.114758pubmed: 39613209google scholar: lookup
  68. Itzhacki J, Clesse D, Goumon Y, Van Someren EJ, Mendoza J. Light Rescues Circadian Behavior and Brain Dopamine Abnormalities in Diurnal Rodents Exposed to a Winter-like Photoperiod. Brain Struct. Funct. 2018;223:2641–2652.
    doi: 10.1007/s00429-018-1655-8pubmed: 29560509google scholar: lookup
  69. Donaldson MT, McDonnell SM, Schanbacher BJ, Lamb SV, McFarlane D, Beech J. Variation in Plasma Adrenocorticotropic Hormone Concentration and Dexamethasone Suppression Test Results with Season, Age, and Sex in Healthy Ponies and Horses. J. Vet. Intern. Med. 2005;19:217–222.
  70. Staniar WB, Kronfeld DS, Akers RM, Harris PA. Insulin-like Growth Factor I in Growing Thoroughbreds. Anim. Physiol. Nutr. 2007;91:390–399.
  71. Scheibe KM, Streich WJ. Annual Rhythm of Body Weight in Przewalski Horses (Equus Ferus Przewalskii). Biol. Rhythm. Res. 2003;34:383–395.
  72. Yamazaki S, Numano R, Abe M, Hida A, Takahashi R, Ueda M, Block GD, Sakaki Y, Menaker M, Tei H. Resetting Central and Peripheral Circadian Oscillators in Transgenic Rats. Science 2000;288:682–685.
    doi: 10.1126/science.288.5466.682pubmed: 10784453google scholar: lookup
  73. Collery A, Browne JA, O’Brien C, Sheridan JT, Murphy BA. Optimised Stable Lighting Strengthens Circadian Clock Gene Rhythmicity in Equine Hair Follicles. Animals 2023;13:2335.
    doi: 10.3390/ani13142335pmc: PMC10376498pubmed: 37508112google scholar: lookup
  74. Lutzer A, Nagel C, Aurich J, Murphy BA, Aurich C. Development of Foals Until One Year of Age When the Dam Was Exposed to Blue Monochromatic Light Directed at One Eye During Late Pregnancy. J. Equine Vet. Sci. 2022;112:103922.
    doi: 10.1016/j.jevs.2022.103922pubmed: 35257825google scholar: lookup
  75. El-Missiry MA, Fayed TA, El-Sawy MR, El-Sayed AA. Ameliorative Effect of Melatonin against Gamma-Irradiation-Induced Oxidative Stress and Tissue Injury. Ecotoxicol. Environ. Saf. 2007;66:278–286.
    doi: 10.1016/j.ecoenv.2006.03.008pubmed: 16793135google scholar: lookup
  76. West KE, Jablonski MR, Warfield B, Cecil KS, James M, Ayers MA, Maida J, Bowen C, Sliney DH, Rollag MD. Blue Light from Light-Emitting Diodes Elicits a Dose-Dependent Suppression of Melatonin in Humans. J. Appl. Physiol. 2011;110:619–626.
  77. Takasu NN, Hashimoto S, Yamanaka Y, Tanahashi Y, Yamazaki A, Honma S, Honma K. Repeated Exposures to Daytime Bright Light Increase Nocturnal Melatonin Rise and Maintain Circadian Phase in Young Subjects under Fixed Sleep Schedule. Am. J. Physiol.-Regul. Integr. Comp. Physiol. 2006;291:R1799–R1807.
    doi: 10.1152/ajpregu.00211.2006pubmed: 16840653google scholar: lookup
  78. Dauchy RT, Dauchy EM, Hanifin JP, Gauthreaux SL, Mao L, Belancio VP, Ooms TG, Dupepe LM, Jablonski MR, Warfield B. Effects of Spectral Transmittance through Standard Laboratory Cages on Circadian Metabolism and Physiology in Nude Rats. J. Am. Assoc. Lab. Anim. Sci. 2013;52:146–156.
    pmc: PMC3624782pubmed: 23562097

Citations

This article has been cited 0 times.